Hepatitis viruses take advantage of traditional practices to increase the burden of hepatocellular carcinoma in Tunisia
- 73 Downloads
Hepatocellular carcinoma (HCC) is a major public health issue in Africa. In Tunisia, hepatitis B virus (HBV) is known to be an important risk factor for HCC in the south of the country, but the role played by hepatitis C virus (HCV) still remains unclear. The aim of the current case-control study was to identify risk factors for HCC development in the northern part of the country. Clinical and biological data including viral hepatitis status (serological and molecular) and non-infectious risk factors from 73 patients with HCC and 70 control subjects without hepatic diseases were collected. The mean age of the patients was 63 ± 10 years, and the ratio of males to females was 1.1. HCC occurred in cirrhotic liver in 72.0% of the cases. HCV infection was the dominant risk factor (64.3% of cases); the presence of HBV was observed in 53.4% of the cases. Occult hepatitis B and C were implicated, respectively, in 30.1% and 9.6% of the cases. HCV genotype 1b was predominant. Patients originating from western Tunisia formed a homogeneous group, characterized by significantly higher rates of tattoos or scarifications (83%) and HCV infection (80%) than those from other parts of the country. Chronic HCV infection is currently the primary risk factor for HCC in Tunisia; HBV infection remains frequent in its overt or occult infection forms. Traditional esthetic practices apparently contribute to increasing the burden of terminal liver diseases in western Tunisia.
This study was supported by the “Tunisian Secretariat for Scientific Research and Technology SERST for the Tunisian part of the study (LR: Epidémiologie et diversité génétique des virus hépatiques et des entérovirus, Contract: LR11SP09)”.
Compliance with ethical standards
Conflict of interest
The authors declare no conflicts of interest.
- 3.Levero M (2006) Viral hepatitis and liver cancer: the case of hepatitis C. Oncogene 25:3834–3847Google Scholar
- 4.Venook AP, Papandreou C, Furuse J, de Guevara LL (2010) The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist 4:5–13Google Scholar
- 6.Allain JP (2005) Occult hepatitis B virus infection. Hep B Annual 2:14–30Google Scholar
- 7.DeMitri MS, Cassini R, Bernardi M (2010) Hepatitis B virus-related hepatocarcinogenesis: molecular oncogenic potential of clear or occult infections. Eur J Cancer 46:2178–2186Google Scholar
- 8.Morales-Romero J, Vargas G, García-Román R (2014) Occult HBV infection: a facelessenemy in liver cancer development. Viruses 8:1590–1611Google Scholar
- 9.Registre des cancers Nord-Tunisie 1993–2003. Institut national de la santé publique. Ministère de la santé publiqueGoogle Scholar
- 11.Bahri O, Ezzikouri S, Alaya-Bouafif NB, Iguer F, Feydi AE, Mestiri H et al (2011) First multicenter study for risk factors for hepatocellular carcinoma development in North Africa. World J Hepatol 27:24Google Scholar
- 16.Sibnarayan D et al (2008) Analysis of hepatitis B virus X gene phylogeny, genetic variability and its impact on pathogenesis: implications in Eastern Indian HBV carriers. Virology 382(2):190–198Google Scholar
- 17.Chemin I, Zoulim F, Merle P, Arkhis A, Chevallier M, Kay A et al (2001) High incidence of hepatitis B infections among chronic hepatitis cases of unknown a etiology. J Hepatol 31:447–454Google Scholar
- 20.Miquel M, Sopeña J, Vergara M, Gil M, Casas M, Sánchez-Delgado J et al (2012) Factors related to survival in hepatocellular carcinoma in the geographic area of Sabadell (Catalonia, Spain). Rev Esp Enferm Dig 1:242Google Scholar
- 21.Appel-da-Silva MC, da Silva Miozzo SA, de Azevedo DI, Tovo CV, Branco F, de Mattos AA (2016) Incidence of hepatocellular carcinoma in outpatients with cirrhosis in Brazil: a 10-year retrospective cohort study. World J Gastroenterol 14:10219Google Scholar
- 47.Raimondo G, Locarnini S, Pollicino T, Levrero M, Zoulim F, Lok AS (2019) Update of the statements on biology and clinical impact of occulthepatitis b virus infection. J Hepatol 71:371–397Google Scholar